Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Director Preclinical Operations at Isarna Therapeutics, Germany
Katja Wosikowski currently works for Isarna Therapeutics as Director Preclinical Operations, where she is responsible for advancing Isarna´s 2nd generation antisense molecules into the clinic. Besides being a licensed pharmacist, she holds a doctorate in cellular biology from the University of Basel and did a 5-year postdoctoral research stay at the National Cancer Institute, Bethesda, USA. During her 20+ years of experience in drug discovery and development, she has been in positions with increasing responsibilities in biopharmaceutical companies, managing and leading preclinical development projects of innovative compounds including small molecule inhibitors, antibodies and antisense molecules, as well as herbal drugs. During this time she gathered experience in different therapeutic fields such as oncology, ophthalmology and respiratory diseases.